UNSPSC 51461537: Gelsemium

This classification denotes derivations of a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 639KR60Q1Q, which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 29929 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Gentianales, Family Gelsemiaceae, Genus Gelsemium Juss.

UNSPSC 51461537 Gelsemium is a Commodity code representing botanical pharmaceutical ingredients and prepared plant extracts used in over-the-counter and prescription remedies. State and local government procurement under this code primarily targets generic multi-source pharmaceuticals and OTC products distributed through cooperative purchasing agreements to public health facilities, correctional institutions, and municipal medical services. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, solicits manufacturers and distributors to supply comprehensive product lines with specific National Drug Codes (NDCs), packaging configurations, and pricing structures that meet FDA compliance and cGMP standards. Vendors must maintain contractual relationships with authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and demonstrate EDI capability and flexible pricing options spanning flat price, net price formats, and WAC-minus structures. Contract awards carry administrative fees of 3 percent on all purchases and performance penalties ranging from $200 to $1,500 per violation for late reporting, missed timelines, or improper class-of-trade denials.

MMCAP's cooperative purchasing vehicle extends across Minnesota and Oregon, with recent activity concentrated in multistate purchasing consortiums rather than individual municipal or county procurement offices. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) for Generic Multi-Source Pharmaceuticals and OTC Products with a response deadline of March 26, 2026 and contract effectiveness date of July 1, 2026. Evaluation weighting emphasizes price competitiveness at 75 percent, with secondary weight on fixed pricing (10 percent) and administrative compliance (15 percent combined). Vendors must provide products available in the marketplace by May 15, 2026, maintain comprehensive insurance including $5,000,000 commercial general liability per occurrence, and comply with the Drug Supply Chain Security Act (DSCSA). The contract term is two years for new responders with optional extensions, while incumbent amendments align with existing agreement expirations through June 30, 2028. No specific set-aside designations or dollar ranges are disclosed in the solicitation.